News Focus
News Focus
Replies to #77581 on Biotech Values
icon url

grandpatb

05/08/09 6:29 AM

#77593 RE: DewDiligence #77581

The Fire This Time: Is This Health Care's Moment?
By Joe Klein
Time Thursday, May. 07, 2009

Economic crises come and go, but entitlements are forever. The Great Depression eventually dissipated, but Franklin Roosevelt's crown jewel — the Social Security system — is still with us. And so it will be with the Obama Administration. The early headlines have been all about the President's efforts to repair the financial system and jump-start the economy. If he succeeds, he probably will be re-elected. But Barack Obama's place in history will be determined by the long-term structural changes he initiates, and his most important legacy battle is just beginning as Congress tackles the holy grail of modern liberalism, a universal health-care system.

The President has been clever about this. He hasn't made it the centerpiece of his Administration — and a fat target for his opponents — as Bill Clinton did. He hasn't proposed a specific plan, allowing, instead, a proposal to percolate through the Congress. "Everything about this process seems the polar opposite of 15 years ago," says John Rother of AARP. "The Administration seems determined not to make the same mistakes as Clinton did." (See the five truths about health care in America.)

Indeed, Democrats have a history of strategic idiocy when it comes to health care. Nearly 40 years ago, Richard Nixon proposed a universal system in which employers would be required to pay for their employees' coverage, but Democrats blocked it because they favored a government-run single-payer system. Twenty years later, Bill and Hillary Clinton proposed a system similar to Nixon's — but failed to bring aboard moderate Republicans, who favored a universal system based on requiring individuals rather than employers to participate. In the 2008 campaign, Obama and Hillary Clinton proposed plans that looked very much like the 1993 Republican scheme — do you detect a pattern here? — and the congressional debate, which will take place this summer, begins there.

This time, with significant Democratic majorities in both houses of Congress, there is real optimism that a universal plan will be passed and enacted. But Clinton also had Democratic majorities — and strong public approval, at first. This time, because of the rules agreed on in the arcane budget process, Democrats will need only a simple majority vote in the Senate. But the process could run into the same two roadblocks that caused universal health insurance to fail in the past: the specter of "socialized medicine" and the fear that the cost of the program will, like that of other entitlements, spiral out of control.

In the 2008 campaign, Obama and Clinton worked overtime to assure voters that if they liked their current health-care coverage, they could keep it — that is, the system would remain a private one, presided over by a more strictly regulated insurance industry. And in the months since the election, the insurers have indicated that they will play ball: they've said they will cover everyone, at the same rate, regardless of pre-existing condition. (There are caveats: the details of health insurance are devilish, and pitched battles are fought over arcana too obscure to cover in this space.) But more-liberal Democrats have decided to press the issue. They have proposed a "public" health-insurance option, similar to Medicare. They argue, correctly, that the profits made by insurance companies are a good part of what makes health care so expensive in the U.S. and that a public option is needed to keep the insurers honest. Needless to say, the insurers are vehemently opposed to this and will unleash a torrent of negative advertising and lobbying power if the final bill includes it.

The President recently told a remarkable story about his grandmother. In the last months of her life — she was dying of cancer — she broke her hip and received a hip replacement from Medicare. "I don't know how much that hip replacement cost," Obama told the New York Times, and he questioned whether giving people "a hip replacement when they're terminally ill is a sustainable model." This is the most sensitive health-care issue imaginable. But the question of whether the government can decide which health-care treatments are appropriate is central to whether an affordable universal system can be devised. Part of the answer is implicit in the electronic medical-records system that Obama has proposed: it will be easier to determine which treatments are cheaper and more effective. The other part of the answer involves an essential change in Medicare, from fee-for-service to a managed-care system that decides whether a hip replacement is necessary for a terminal cancer patient. Since most of the baby boomers about to enter the Medicare system have been living with managed care for the past 20 years, a gradual transition may not be impossible.

My guess is that the public option is a bargaining chip that will be cashed in to gain support from moderate Republicans and Democrats as crunch time approaches. The real battle, and the fate of this liberal dream, will be fought over what gets covered and who decides.


Copyright © 2009 Time Inc. All rights reserved.
icon url

DewDiligence

02/16/14 4:37 PM

#174306 RE: DewDiligence #77581

Barron’s touts CVS, but I’m skeptical of all PBMs as long-term buys:

http://online.barrons.com/article/SB50001424053111903506304579374920237274990.html

Based in Woonsocket, R.I., CVS has more than 7,600 stores, making it the second-largest drug chain behind Walgreen (WAG). Thanks to a 2007 merger with Caremark, it's also the second-largest pharmacy benefit manager behind Express Scripts (ESRX), which merged with Medco Health Solutions in 2012. But it surpasses both in terms of total prescription revenue, with nearly a quarter of the market.

This past week, CVS reported 2013 revenue of $126.8 billion, up 3%, on healthy growth for drug plans and in-store pharmacies offset by weak growth in front-of-store sales.

CVS' generic dispensing rate rose to 81.4% last year from 79.2% in 2012. Generics are much cheaper than branded drugs, of course, but they can carry gross profit margins of over 40%, versus single-digit margins for branded drugs. So while they don't do much for revenue, they can provide a handsome boost to earnings. CVS could raise its generic dispensing rate to 85% by 2016.